The MEP Friends of the Liver group held a meeting in the European Parliament on March 22nd 2017.
The focus of the meeting was on the burden of Hepatitis C in the Baltic and Central and South Eastern EU member states. Speakers from the European Parliament, the European Commission the European Monitoring Centre for Drugs and Drug Addiction, patients groups and hepatology community presented and discussed the situation and the steps needed to get better access to treatment for HCV patients in the region.
Download the presentations from the Friends of the Liver event.
The 2016 ELPA Hep-CORE Report - European Liver Patients Association
The EASL HCV treatment guidelines: Who should be treated and when - Prof Helena Cortez-Pinto, EASL EU Policy Councillor
HCV Romanian framework - Prof Adrian Streinu-Cercel MD, PhD, HC
Are patients getting the treatment they need in Poland? - Dr hab.med. Jerzy Jaroszewicz, Vice-President of the Polish Society for the Study of the Liver
HCV infection in Bulgaria -Marieta Simonova, MD
Hepatitis C: Policy in Action - Ricardo Baptista Leite MP, MD, PhD(C)
High consumption of red and processed meat linked to non-alcoholic fatty liver disease and insulin resistance
Gastrointestinal hormone measurably improved symptoms of non-alcoholic fatty liver disease
Raising awareness about alcohol-related liver disease in women
Subscribe to the EASL newsletter